About Javeri
Product & Services
Equity
Derivatives
Mutual Funds
IPO
Corporate Info
Research
Contact Us
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME
>
CORPORATE INFO
>
HISTORICAL VOLUME
Historical
Volume
Gufic Biosciences Ltd.
BSE Code
509079
ISIN Demat
INE742B01025
Book Value
61.17
NSE Code
GUFICBIO
Dividend Yield %
0.03
Market Cap
36447.68
P/E
59.61
EPS
6.10
Face Value
1
Exchange :
BSE
NSE
Period From :
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
DEC
2025
2024
Period To :
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
DEC
2025
2024
Date
Open Price(Rs.)
High Price(Rs.)
Low Price(Rs.)
Close Price(Rs.)
Volume
Turnover
18-Sep-2025
362.15
367.60
359.65
363.45
2988
1083575
17-Sep-2025
364.25
365.05
353.65
353.90
3413
1222038
16-Sep-2025
367.30
368.15
362.00
364.25
3359
1224643
15-Sep-2025
368.00
368.85
365.05
367.30
1275
468284
12-Sep-2025
362.30
369.30
361.00
368.40
1252
454361
11-Sep-2025
371.00
372.45
360.25
362.95
4103
1498716
10-Sep-2025
368.50
373.15
366.70
371.55
1407
519510
09-Sep-2025
353.05
371.05
350.70
369.85
4299
1546510
08-Sep-2025
356.15
360.00
352.95
356.50
1444
513760
05-Sep-2025
363.05
365.00
353.30
355.00
4070
1460947
04-Sep-2025
364.25
370.30
359.85
365.25
322675
117131922
03-Sep-2025
366.40
367.15
361.60
362.90
2143
781657
02-Sep-2025
363.00
367.75
361.15
366.70
1667
606232
01-Sep-2025
363.15
365.40
361.25
362.95
1629
590995
Page
1
of
1
Prev
||
Next
Disclaimer
|
Privacy Policy
| Grievance |
FAQ
|
Sitemap |
Client Registration |
Useful Links
|
Anti Money Laundering
|
Inactive Client Policy
|
Scores
Vernacular Kyc
|
Advisory For Investors
|
Investor Adviser
|
Filing complaints on SCORES - Easy & quick
|
Policy on PMLA
|
Publishing of investor charter information
|
Annexure A – Investor charter of brokers
|
Annexure A – Investor charter of DP
|
Annexure B –Linked content for information to charter for DP
|
Annexure B & C (investor complaint data) broker & DP
|
Investor Charter & Complaints
|
Advisory-KYC Compliance
|
E-Voting NSE
|
E-Voting BSE
|
Details of Client Bank Accounts
|
Risk Disclosure
|
NSE FO Risk disclosure
|
Details of Research Analyst
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by
Accord Fintech Pvt. Ltd.
CLOSE
X
RISK DISCLOSURES ON DERIVATIVES
9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source:
Click Here.